Call Us : (917) 451-7018 Book Now
Spravato Treatment(ESKetamine) in NYC

#1 Leading Provider of Spravato ® Treatment in New York City

Spravato ® (esketamine) nasal spray is approved by the FDA in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment- resistant depression). Because of the risk of serious adverse outcomes resulting from sedation and dissociation caused by Spravato administration, and the potential for abuse and misuse of the drug, it is only available through a restricted distribution system, under a Risk Evaluation and Mitigation Strategy (REMS).

Our Reviews

What Our Patients Say About Us

Curated combines professional expertise, a safe environment, and a patient-first approach to support transformative mental health journeys.

Thank you so much! My life did a 180 after meeting with the experts from Curated Mental Health. I’m forever grateful!!

They were able to properly diagnose me, manage my medications, and create realistic treatment plans for the long run. (...)

Curated Mental Health has been a Godsend since I have been in NYC. Just walking in the door, one feels a sense of welcome and calm.

From the front desk, then the therapist, and finally technician that monitors patients while taking the esketamine treatment. (...)

It has been a journey to find the right medication, but my doctor has always been so supportive and she makes me feel like a part of the process.

It is a collaborative process, where she asks me for my opinion about the treatment plan and keeps it very person-centered. She is the best!

FAQ
Your Questions Answered

To schedule an appointment, visit our website at www.curatedmentalhealth.com and navigate to the "Book Now" page to fill out the appointment request form. Alternatively, call us at 917-451-7018, and our team will assist you with scheduling and provide available dates and times.

Absolutely! Our providers are highly qualified and experienced in delivering mental health care. They specialize in advanced treatments such as psychedelic-assisted therapy and Transcranial Magnetic Stimulation (TMS), ensuring the highest quality of care for our patients.

IV Ketamine therapy involves administering low doses of ketamine in a controlled medical environment. This approach helps patients manage depressive symptoms and other mental health challenges under the care of our trained providers.

This therapy is designed for individuals with conditions such as Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD), Bipolar Depression, PTSD, or suicidal thoughts. Our team conducts a thorough assessment to ensure the treatment is safe and appropriate for your needs.

Yes, safety is our top priority. We follow strict protocols and guidelines, and our therapists are highly trained to provide a secure and supportive therapeutic experience.

The therapeutic potential of ketamine is well-established, and we remain hopeful that the FDA will expand its recognition of ketamine-based treatments in the near future. Currently, the FDA has approved Spravato (Esketamine nasal spray) for depression, a significant step forward in ketamine-based therapies.

Costs vary depending on the treatment plan. We accept insurance for certain treatments:
  • Cigna, Aetna, and United Healthcare: Spravato, TMS, and medication management.
  • Enthea: Ketamine-Assisted Therapy (KAT). For IV Ketamine/KAP, coverage eligibility is determined through the intake process. Call us at 917-451-7018 for more details.

Treatment typically involves several sessions spaced over time to allow for integration and support. The exact duration depends on individual needs and goals, which are assessed during the intake process.

Eligibility depends on your medical history, assessed during the screening process. Factors like recent brain injuries, ketamine allergies, psychosis, or certain medications (e.g., benzodiazepines, opioids) may be contraindications. Conditions like uncontrolled hypertension, obstructive sleep apnea, or substance use are evaluated on a case-by-case basis.

IV Ketamine therapy is typically available for individuals aged 18 and older.

After treatment, take it easy for the rest of the day—avoid work, exercise, and stressful activities. Reflecting on your experience in a journal can be helpful, and steer clear of violent or intense media to maintain a calm mindset.

Spravato is a nasal spray form of Esketamine, administered under medical supervision. It works by targeting specific receptors in the brain to alleviate symptoms of depression. Sessions are conducted in a safe and supportive setting.

Treatment duration varies but typically involves multiple sessions over weeks or months. Your provider will develop a personalized plan tailored to your needs.

Side effects vary by individual but may include dizziness, nausea, or sedation. These effects are temporary and typically resolve within hours after the session.

Spravato is FDA-approved for individuals aged 18 and older.

Transcranial Magnetic Stimulation (TMS) is a non-invasive treatment that uses magnetic fields to stimulate areas of the brain associated with mood regulation. This therapy is effective for depression and other conditions when other treatments haven’t worked.

A typical TMS treatment course involves daily sessions over 4-6 weeks, with each session lasting about 20-40 minutes. Treatment plans are tailored to your specific needs.

TMS therapy is generally well-tolerated. Possible side effects include mild scalp discomfort or headache during or after the session, which typically resolves quickly.

TMS therapy is generally available for individuals aged 18 and older, with eligibility assessed during the intake process.